A positive stool antigen usually supports giardiasis, but treatment response and digestive recovery follow different timelines. Here is how clinicians separate ongoing infection from a gut that is still healing.
- Detected antigen means Giardia proteins were identified in stool; it usually supports infection but does not measure parasite burden or illness severity.
- Treatment selection depends on symptoms, age, pregnancy, previous medicines, and availability—not the strength of a positive antigen result.
- Tinidazole is commonly prescribed to adults as a single 2 g dose with food; it requires a prescription and an individual safety assessment.
- Illness duration is commonly 2–6 weeks without treatment, although untreated infection can last longer and symptoms may fluctuate.
- Digestive recovery can lag behind parasite clearance because temporary lactose malabsorption and post-infectious bowel dysfunction may continue.
- Ath-dheuchainn is generally unnecessary when symptoms resolve; suspected treatment failure requires attention to timing and specimen collection.
- Persistent infection checks commonly involve 3 stool specimens collected over several days, with CDC guidance advising at least 2 weeks after the last medication dose before re-examination for treatment failure.
- Swimming precautions continue for 2 weeks after diarrhea stops because Giardia can still spread after someone feels better.
- Measadh èiginneach is needed for inability to retain fluids, markedly reduced urination, fainting, bloody stool, or severe localized abdominal pain.
What does a detected Giardia stool antigen mean?
Giardia antigen detected means a stool assay found proteins from Giardia, a microscopic intestinal parasite. A positive result usually supports giardiasis and warrants clinical assessment; symptomatic patients commonly receive prescription treatment. Symptoms can persist after clearance, and repeat testing is usually reserved for persistent or recurrent illness rather than routinely performed after recovery.
A result reported as giardia stool antigen positive is usually qualitative: detected or not detected, rather than a concentration that predicts how sick you should feel. Laboratories may produce internal assay signals, but these are not interchangeable parasite counts; our explanation of toraidhean càileachdail an aghaidh toraidhean tomhasach a’ mìneachadh an eadar-dhealachaidh sin.
The timing changes the interpretation. A first positive sample collected before treatment is different from a positive sample collected 2 days after finishing medication, when residual target material and testing limitations complicate the question of cure; neither result tells you precisely when the parasite was acquired.
My clinical approach, as Thomas Klein, MD, is to separate 3 questions: does the result fit the symptoms, is treatment appropriate, and is the person becoming dehydrated? Kantesti is an AI blood test analyzer that explains associated laboratory findings, not a substitute for a Giardia stool assay or a prescribing clinician; ar buidheann describes that distinction.
How antigen testing differs from PCR and microscopy
Giardia antigen testing detects parasite proteins, PCR detects parasite genetic material, and microscopy looks for parasite structures. These 3 approaches can disagree because their targets, sensitivity, specimen requirements, and vulnerability to collection problems differ. A positive antigen is not an antibody result and does not mean immunity from a previous infection.
PCR, often included in a multiplex gastrointestinal panel, can detect Giardia alongside several other organisms in 1 specimen. That broader panel may reveal a second explanation for diarrhea, but detecting genetic material does not independently establish organism viability, and PCR signal values should not be interpreted as a standardized severity score.
Microscopy depends on what reaches the slide and who examines it. Routine ova-and-parasite examination may miss intermittent shedding; direct fluorescent antibody microscopy is a different, highly sensitive technique that CDC identifies as a diagnostic gold standard, so a report saying only 'microscopy negative' leaves at least 1 useful question unanswered: which method?
Discordance deserves context rather than a vote between tests. If 1 antigen assay is positive but microscopy is negative in a person with greasy diarrhea after untreated-water exposure, the positive remains clinically meaningful; a blood antibody result answers a different question, as explained in positive antibody interpretation.
How long does Giardia last, and which symptoms fit?
Giardia symptoms commonly begin 1–2 weeks after exposure and last 2–6 weeks, although untreated infection can persist longer. Typical symptoms include watery or greasy diarrhea, gas, abdominal cramps, nausea, fatigue, and weight loss. Some infected people have no symptoms, and others experience alternating better and worse days.
Greasy, foul-smelling stool reflects impaired absorption rather than a unique visual fingerprint of Giardia. Floating stool alone can result from gas, and yellow stool has several causes; yellow stool patterns are more useful when considered alongside weight change and the number of loose stools over 24 hours.
Consider an illustrative 34-year-old traveler whose diarrhea improves for 3 days and then returns before treatment. That interruption does not establish spontaneous clearance: intermittent symptoms and shedding can make the illness feel like separate episodes, while a household member with no diarrhea may still carry and transmit the parasite.
Successful treatment often brings noticeable improvement within several days, but there is no reliable deadline by which every bowel movement must normalize. A 7-day symptom diary recording stool frequency, food triggers, hydration, and weight direction provides better follow-up information than comparing today's stool appearance with yesterday's photograph.
How clinicians choose Giardia infection treatment
Giardia infection treatment commonly uses tinidazole, metronidazole, or nitazoxanide. The choice depends on age, pregnancy or breastfeeding, interactions, previous treatment, formulation, and local availability. A detected antigen does not identify drug susceptibility, so clinicians cannot choose the best medicine from the positive result alone.
Common adult regimens include tinidazole 2 g once with food, metronidazole 250 mg three times daily for 5–7 days, or nitazoxanide 500 mg twice daily with food for 3 days. These are examples, not instructions for self-treatment; local guidelines, product labeling, and individual circumstances can justify a different regimen.
Tinidazole combines a short schedule with strong efficacy evidence. Ordóñez-Mena, McCarthy, and Fanshawe's network meta-analysis found greater parasitological cure with tinidazole than metronidazole across the included trials, although study quality and follow-up varied (Ordóñez-Mena et al., 2018); completing 1 prescribed dose can also be easier than remembering multiple daily doses.
An asymptomatic positive result does not always require the same decision as symptomatic diarrhea. Clinicians may consider treatment when household transmission, vulnerable contacts, or occupational rules make carriage consequential; Kantesti cannot prescribe these medicines, and our discussion of medication safety monitoring distinguishes result interpretation from treatment authorization.
Which treatment precautions change the prescription?
Pregnancy, breastfeeding, childhood, anticoagulant use, and previous drug reactions can change the safest Giardia prescription. These circumstances should be disclosed before the first dose. Product-specific advice matters: 2 medicines used for the same parasite may have different age approvals, feeding precautions, and interaction risks.
Pediatric doses are generally weight-based, not a fraction of an adult tablet guessed at home. For example, tinidazole labeling permits a single 50 mg/kg dose, up to 2 g, for giardiasis in children older than 3 years; the child's clinician must check local approval, formulation, and whether another medicine is more appropriate.
Pregnancy needs an individual assessment of symptom severity, hydration, gestational timing, and drug evidence—not an automatic decision to delay all care. Tinidazole is generally avoided in pregnancy, particularly early pregnancy, and its labeling recommends interrupting breastfeeding during treatment and for 72 hours after the last dose; alternatives require clinician advice.
Metronidazole and tinidazole can increase warfarin's anticoagulant effect, making an INR monitoring plan relevant even for a short course. See atharrachaidhean INR an dèidh antibiotics for the reasoning; alcohol restrictions also follow the prescribed product's instructions, commonly extending 72 hours after nitroimidazole treatment, rather than an assumption that 1 symptom-free evening proves safety.
What helps during the first days of recovery?
Oral rehydration and adequate food intake support Giardia recovery, but neither replaces antiparasitic treatment when it is indicated. Use a commercial oral rehydration solution mixed exactly as directed when diarrhea is substantial. Review the direction of change over 24–48 hours rather than expecting a normal stool immediately after medication.
Small, frequent sips can be easier to retain than a large glass taken quickly. For many otherwise healthy adults, roughly 200–250 mL of additional oral rehydration solution after each loose stool is a practical starting point, adjusted to thirst and losses; children and people with heart or kidney disease need individualized advice.
Plain water is useful, but substantial diarrhea also removes sodium and other electrolytes. Potassium below 3.5 mmol/L is generally low, although the laboratory range applies, and worsening weakness or palpitations can justify checking an pannal electrolytes rather than simply drinking progressively larger amounts of water.
Dehydration can raise creatinine and temporarily lower calculated eGFR without proving chronic kidney disease. Kantesti is an AI blood test interpretation platform that can explain those accompanying results in context; a dehydration-related eGFR change is best reassessed after clinical recovery when appropriate, not labeled permanent from 1 dehydrated sample.
Why symptoms can persist after Giardia clears
Digestive symptoms can continue after Giardia clears because intestinal recovery is slower than parasite elimination. Temporary lactase deficiency, altered bowel sensitivity, and post-infectious irritable bowel syndrome are recognized explanations. A negative follow-up investigation and ongoing symptoms are not contradictory; they may describe 2 different stages of the same illness.
Lactase sits on the small-intestinal brush border, so Giardia-related surface disruption can make previously tolerated milk trigger gas and diarrhea. A 1–2 week trial of reduced lactose, followed by gradual reintroduction as symptoms settle, may be reasonable; lactose-free dairy retains protein and calcium, and complete dairy avoidance is not automatically necessary.
Post-infectious symptoms can also last much longer than temporary food intolerance. In a Norwegian outbreak cohort assessed 6 years later, IBS occurred in 39.4% of previously infected participants versus 11.6% of controls (Hanevik et al., 2014); those figures describe that particular cohort, not the expected outcome for every person with a positive antigen.
The pattern helps choose the next step: milk-triggered symptoms suggest malabsorption, whereas pain linked to defecation and fluctuating stool consistency may suggest post-infectious bowel dysfunction. In children, stool pH interpretation has limitations; 1 low result cannot identify Giardia or prove that a restrictive diet is needed.
What else should be checked if diarrhea continues?
Persistent diarrhea after Giardia treatment may reflect ongoing infection, reinfection, medication effects, or a separate digestive condition. Once appropriate stool investigations are negative, repeating antiparasitic prescriptions without reassessment can delay the correct diagnosis. Symptoms lasting 4 weeks or longer usually deserve a structured chronic-diarrhea review, sooner if warning signs appear.
Persistent bloating is not enough to diagnose small-intestinal bacterial overgrowth. A clinician may consider breath testing when risk factors and the symptom pattern support it, but test preparation and interpretation matter; our explanation of SIBO breath test limits shows why 1 positive-looking curve should not automatically trigger another antibiotic.
Celiac disease, inflammatory bowel disease, pancreatic problems, and another intestinal pathogen can enter the differential when weight loss, prolonged diarrhea, or nutritional abnormalities persist. If celiac testing is planned, removing gluten first can reduce test sensitivity; gluten exposure before testing should be discussed before starting a restrictive diet for 2 or more weeks.
The medication timeline often provides a simpler explanation than a new diagnosis. Nausea beginning with treatment, diarrhea associated with magnesium supplements, or symptoms after another antibiotic should be recorded with dates; in an illustrative patient whose stools improve by day 4 but bloating worsens after dairy, I would reassess the trigger before assuming resistance.
When should a positive Giardia test be repeated?
Repeat Giardia testing is usually appropriate when symptoms persist or recur, not routinely after symptoms resolve. In its treatment-failure pathway, CDC advises waiting at least 2 weeks after the last anti-Giardia medication dose before re-examination, using 3 stool specimens collected over several days. Worsening illness requires assessment without waiting for that interval.
The CDC Patient Care for Giardia Infection guidance uses antigen testing or microscopy on 3 specimens to assess whether infection remains (CDC, 2024). If those investigations are negative, ongoing infection becomes less likely even when symptoms continue; serial specimens address intermittent shedding rather than representing 3 identical confirmations from the same container.
An early positive result is harder to use as a clean treatment endpoint. Antigen proteins and genetic targets do not disappear according to 1 universal timetable, and laboratories differ in assay performance; ask which method was used, the collection date relative to the final dose, and whether the result would actually change management.
Public-health or workplace requirements can create exceptions, particularly during outbreaks or for specific childcare and food-handling roles. Kantesti separates test interpretation from clearance decisions; our inbhean dòigh-obrach clionaigeach explain why a positive or negative result must be interpreted with specimen timing and the relevant local rule, not 1 generic return-to-work promise.
What happens when Giardia remains positive after treatment?
A persistently positive Giardia result should prompt checks for reinfection and inadequate treatment before assuming drug resistance. Clinicians review the exact prescription, doses taken, vomiting, repeat exposures, and specimen timing. Confirmed infection despite an adequate regimen may require specialist-directed treatment using a different medicine or combination rather than blindly repeating the first course.
A returning positive result does not distinguish relapse from a fresh exposure. Ask whether untreated water is still being consumed, a symptomatic household member remains unassessed, or childcare exposure continues; a 2-week gap between improvement and renewed diarrhea can fit several explanations, so that interval alone cannot establish resistance.
Medication delivery is another practical checkpoint. Vomiting soon after a single dose, stopping a 7-day course early, or receiving an incorrect weight-based dose can reduce effective treatment; CDC places reinfection and inadequate treatment checks before combination therapy in its persistent-infection pathway (CDC, 2024).
Repeated confirmed giardiasis despite appropriate treatment can justify evaluating immune function, especially with other recurrent infections or unexplained nutritional decline. Clinicians may review IgG, IgA, and IgM together rather than ordering 1 isolated measurement; our stiùireadh againn air toraidhean immunoglobulin explains why low IgA and broader antibody deficiencies require different follow-up.
How to prevent spread and reinfection during recovery
Giardia spreads when microscopic cysts from fecal contamination are swallowed through water, food, hands, or contaminated objects. People may remain infectious after symptoms improve. Avoid swimming while diarrhea continues and for 2 weeks after it stops; routine pool chlorination does not immediately eliminate Giardia.
Soap-and-water handwashing after toilet use or diaper changes and before food preparation is a practical priority. Clean visible contamination before applying a suitable disinfectant according to its instructions; 1 quick wipe of a still-soiled surface is less reliable because organic material can interfere with disinfection.
For drinking water of uncertain safety, CDC recommends bringing water to a rolling boil for 1 minute, or 3 minutes above 6,500 feet, approximately 2,000 metres. A filter specifically rated to remove cysts, such as an appropriate absolute 1-micron filter, can help with Giardia but does not automatically remove every virus or chemical contaminant.
Household contacts with symptoms should seek assessment rather than share the patient's prescription. Food handling, childcare attendance, and intimate contact involving possible fecal exposure need additional precautions; contagiousness after gastroenteritis illustrates why feeling well and no longer transmitting are 2 separate questions, although each organism has its own rules.
Which symptoms need urgent medical assessment?
Seek urgent assessment for severe dehydration, inability to retain fluids, fainting, confusion, bloody or black stool, or severe localized abdominal pain. Giardia does not explain every abnormal symptom in someone with a positive test. Infants, older adults, pregnant patients, and immunocompromised people may need review earlier, even within the first 24 hours of worsening diarrhea.
Markedly reduced urination matters more than a reassuring stool result. An adult producing little or no urine for roughly 8–12 hours despite attempted drinking, particularly with dizziness or a rapid pulse, should obtain urgent advice; do not use that interval as a reason to wait if confusion, collapse, or rapid deterioration develops.
Visible blood, black tarry stool, or high fever should broaden the diagnosis beyond uncomplicated giardiasis. A temperature around 39°C with worsening abdominal symptoms warrants prompt review, and our guide to èiginn fala ann an stòl explains why color, volume, and associated symptoms change the response.
A normal inflammatory marker does not make severe abdominal pain safe to monitor at home. For example, a CRP of 3 mg/L may fall within a laboratory's normal range but cannot exclude an early abdominal emergency; eas-aonta WBC agus CRP is a reminder that clinical examination takes priority over 1 reassuring number.
Where blood tests and AI interpretation can help
Blood tests assess consequences of Giardia illness, such as dehydration or nutritional problems; they do not replace stool testing to establish infection or clearance. A CBC, electrolytes, kidney function, or selected nutritional markers may be useful when symptoms or examination justify them. An uncomplicated, improving case does not automatically require 1 large laboratory panel.
Persistent fatigue after diarrhea can reflect inadequate intake, sleep disruption, iron deficiency, or post-infectious illness. A hemoglobin below about 12 g/dL in a nonpregnant adult woman or 13 g/dL in an adult man generally suggests anemia, but local ranges and clinical context apply; fatigue alone cannot identify the cause or justify every supplement.
Kantesti is an AI biomarker interpretation platform that helps explain accompanying CBC, electrolyte, and kidney results rather than diagnosing Giardia from them. Our stiùireadh teicneòlais AI describes the interpretation workflow; 1 uploaded report should be considered alongside symptoms, medicines, hydration, and the actual stool assay.
My editorial rule as Thomas Klein, MD, is simple: never let a normal blood panel overrule a worrying history, and never let an AI explanation authorize another antiparasitic course. Kantesti's bòrd comhairleachaidh meidigeach provides information about our medical expertise; ongoing symptoms beyond 4 weeks deserve clinician-led reassessment rather than escalating diet restrictions or repeatedly checking the same biomarker.
Stòran rannsachaidh agus foillseachaidhean obair-lann co-cheangailte
The clinical recommendations here draw on CDC Giardia guidance and peer-reviewed research on treatment and post-infectious outcomes. As of October 24, 2026, the practical distinction remains infection clearance versus symptom recovery. The 2 Zenodo guides below address accompanying kidney or urine findings; neither is evidence that a Giardia stool antigen has cleared.
Treatment comparisons come from Ordóñez-Mena et al. (2018), while the 6-year post-infectious outcomes come from Hanevik et al. (2014); CDC's clinical-care pathway supplies the repeat-testing and treatment-failure framework. Kantesti's inbhean susbaint mheidigeach distinguish clinical research from educational repository publications, because a DOI identifies a document but does not establish peer review.
BUN/Creatinine Ratio Explained: Kidney Function Test Guide. (n.d.). Zenodo. https://doi.org/10.5281/zenodo.18207872. This publication provides background for kidney markers during dehydration, not a diagnostic rule for Giardia; the Rannsachadh foillseachaidhean air ResearchGate agus Rannsachadh foillseachaidh Academia.edu are discovery links, not verified hosted copies.
Urobilinogen in Urine Test: Complete Urinalysis Guide 2026. (n.d.). Zenodo. https://doi.org/10.5281/zenodo.18226379. The stiùireadh eadar-mhìneachaidh urinalysis nas fharsainge concerns urinary findings rather than parasite clearance; its Rannsachadh Rannsachaidh ResearchGate agus Rannsachadh Rannsachaidh Academia.edu likewise do not establish an independently reviewed publication record.
Ceistean Bitheanta
A bheil lorgadh antigen Giardia a’ ciallachadh gu bheil galar gnìomhach orm?
Tha lorgadh antigen Giardia a’ ciallachadh gun deach pròtainean a’ pharaisit a lorg anns an stòl agus mar as trice tha e a’ toirt taic do dh’fhaireachdainn làithreach, gu h-àraidh mus tèid làimhseachadh a thoirt do chuideigin aig a bheil comharraidhean co-fhreagarrach. Chan eil an toradh a’ tomhas uallach nam paraisitean no a’ dearbhadh an dearbh cheann-latha a fhuair an neach an galar. Tha e nas duilghe sampall a chaidh a chruinneachadh 2 là às dèidh cungaidh-leighis a mhìneachadh mar fhianais air fàilligeadh làimhseachaidh na sampall leanmhainn a chaidh a ghabhail aig àm iomchaidh. Bruidhinn ris an dotair mu dheidhinn an toraidh, gu h-àraidh ma mhaireas na comharraidhean no mura robh dùil ris an lorg.
Dè an làimhseachadh àbhaisteach airson antigen Giardia dearbhach ann an stòl?
Mar as trice thèid gabhaltachd Giardia le comharraidhean a làimhseachadh le tinidazole, metronidazole no nitazoxanide air òrdugh-cungaidh. Is e aon chùrsa làimhseachaidh cumanta do dh’inbhich 2 g de tinidazole aon turas le biadh; tha metronidazole thar 5–7 làithean no nitazoxanide thar 3 làithean nan roghainnean eile. Faodaidh aois, torrachas, beathachadh-cìche, eadar-obrachaidhean le cungaidhean eile, làimhseachadh roimhe agus na tha ri fhaighinn gu h-ionadail buaidh a thoirt air an òrdugh-cungaidh. Na cleachd cungaidhean a tha air fhàgail agus na roinn làimhseachadh ball den teaghlach riut.
Dè cho fada ’s a mhaireas Giardia an dèidh làimhseachaidh?
0 Giardia bidh comharraidhean a’ tòiseachadh a’ fàs nas fheàrr gu tric taobh a-staigh grunn làithean bho làimhseachadh èifeachdach, ach faodaidh làn shlànachadh an t-siostaim chnàmhaidh ùine nas fhaide a thoirt. Mairidh tinneas samhlachail gun làimhseachadh 2–6 seachdainean gu cumanta, agus uaireannan mairidh e nas fhaide na sin. Faodaidh droch-ghabhail shealach air lactose no mì-ghnìomhachd a’ chaolain an dèidh galar leantainn às dèidh don pharasait a bhith air falbh. Bu chòir comharraidhean a tha a’ fàs nas miosa, dìth-uisgeachaidh no a’ bhuinneach leantainneach ath-mheasadh adhbharachadh seach dàrna òrdugh-leigheis a thoirt seachad gu fèin-obrachail.
Cuin a bu chòir dhomh deuchainn stòl Giardia ath-dhèanamh?
Mar as trice chan eil feum air deuchainn Giardia a-rithist nuair a dh’fhalbhas na comharraidhean. Ma tha amharas ann nach do shoirbhich leis an làimhseachadh, tha an CDC a’ moladh feitheamh co-dhiù 2 sheachdain às dèidh na dòise mu dheireadh de chungaidh-leigheis an aghaidh Giardia mus tèid ath-sgrùdadh a dhèanamh, agus 3 sampallan stòil a chleachdadh a chaidh a chruinneachadh thar grunn làithean. Dh’fhaodadh riaghailtean ionadail slàinte a’ phobaill eisgeachdan a chruthachadh. Feumar tinneas trom no tinneas a tha a’ fàs nas miosa a mheasadh sa bhad, seach feitheamh ris an ùine eadar deuchainnean.
Carson a tha mi fhathast a’ fulang le bloating ma tha na deuchainnean Giardia agam àicheil?
Faodaidh bloating às dèidh sgrùdaidhean àicheil airson Giardia a bhith mar thoradh air droch-ionsachadh lactose sealach, cugallachd nan caolan an dèidh galar, no suidheachadh cnàmhaidh eile. Dh’fhaodadh deuchainn le nas lugha de lactose airson 1–2 sheachdain cuideachadh le bhith a’ comharrachadh brosnachaidh bìdh fhad ’s a tha obair nan caolan a’ tighinn am feabhas. Chan eil comharraidhean leantainneach a’ dearbhadh leotha fhèin gu bheil Giardia fhathast an làthair. Tha call cuideim, a’ bhuinneach air an oidhche, fuil anns an stòl, no comharraidhean a mhaireas nas fhaide na 4 seachdainean a’ ciallachadh gu bheil feum air ath-sgrùdadh clionaigeach eagraichte.
An urrainn dhomh Giardia a sgaoileadh às dèidh dhan bhuinneach agam stad?
Faodar Giardia a sgaoileadh fhathast an dèidh don bhuinneach fàs nas fheàrr, oir dh’fhaodadh cistean miocroscopach a bhith gan cur a-mach anns an stòl fhathast. Tha CDC a’ comhairleachadh gun a bhith a’ snàmh airson 2 sheachdain an dèidh dhan bhuinneach stad. Nigh do làmhan le siabann is uisge an dèidh dhut an taigh-beag a chleachdadh agus mus ullaich thu biadh, agus lean na riaghailtean ionadail a thaobh làimhseachadh bìdh no cùram-chloinne. Bu chòir do bhuill an teaghlaich aig a bheil comharraidhean measadh fa leth iarraidh seach cungaidh-leigheis a roinn.
Faigh Mion-sgrùdadh Deuchainn Fala le Cumhachd AI an-diugh
Thig còmhla ri còrr is 2 mhillean neach air feadh an t-saoghail a tha a’ earbsa Kantesti airson mion-sgrùdadh sa bhad, ceart air deuchainnean obair-lann. Luchdaich suas na toraidhean deuchainn fala agad agus faigh mìneachadh coileanta air biomarcair 15,000+ ann an diogan.
📚 Foillseachaidhean Rannsachaidh le Iomraidhean
Klein, T., Mitchell, S., & Weber, H. (2026). Mìneachadh air Co-mheas BUN/Creatinine: Stiùireadh airson Deuchainn Gnìomh nan Dubhagan. Rannsachadh Leigheis AI Kantesti.
Klein, T., Mitchell, S., & Weber, H. (2026). Urobilinogen ann an Deuchainn Fuaime: Stiùireadh Coileanta air Urinalysis 2026. Rannsachadh Leigheis AI Kantesti.
📖 Iomraidhean Meidigeach Taobh a-muigh
Ionadan airson Smachd Ghalaran is Bacadh (CDC) (2024). Patient Care for Giardia Infection. CDC Clinical Care Guidance.
Ordóñez-Mena JM, McCarthy ND, Fanshawe TR (2018). Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials. Journal of Antimicrobial Chemotherapy.
Hanevik K et al. (2014). Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: a controlled prospective cohort study. Clinical Infectious Diseases.
⚕️ Àicheadh Meidigeach
Tha an artaigil seo dìreach airson adhbharan foghlaim agus chan eil e a’ dèanamh comhairle mheidigeach. Cuir fios an-còmhnaidh gu solaraiche cùram slàinte teisteanasach airson co-dhùnaidhean breithneachaidh is leigheis.
Comharran earbsa E-E-A-T
Eòlas
Lèirmheas clionaigeach air a stiùireadh le lighiche air sruthan-obrach mìneachaidh obair-lann.
Eòlas
Fòcas air leigheas obair-lann air mar a bhios bith-chomharraidhean (biomarkers) a’ giùlan ann an co-theacsa clionaigeach.
Ùghdarrasachd
Air a sgrìobhadh le Dr. Thomas Klein le ath-sgrùdadh le Dr. Sarah Mitchell agus Prof. Dr. Hans Weber.
Earbsachd
Mìneachadh stèidhichte air fianais le slighean leanmhainn soilleir gus dragh a lughdachadh.
